278
Participants
Start Date
May 1, 2017
Primary Completion Date
April 24, 2022
Study Completion Date
April 24, 2022
Aripiprazole
Oral adjunctive therapy with aripiprazole, dose adjusted for effectiveness and tolerability.
Repetitive transcranial magnetic stimulation (rTMS)
Adjunctive therapy with transcranial magnetic stimulation, dose adjusted for effectiveness and tolerability.
Venlafaxine XR
Oral switch therapy with venlafaxine, dose adjusted for effectiveness and tolerability.
New York University, New York
University of Pennsylvania, Philadelphia
Roper St. Francis Hospital, Charleston
University of South Florida, Tampa
The University of Alabama School of Medicine, Birmingham
University of Cincinnati, Cincinnati
Northwestern University, Feinberg School of Medicine, Chicago
University of Texas Southwestern Medical Center, Dallas
Baylor College of Medicine, Houston
Pacific Institute of Medical Research, Los Angeles
Stanford University, Stanford
University of British Columbia, Vancouver
University of Manitoba St. Boniface Hospital, Winnipeg
Patient-Centered Outcomes Research Institute
OTHER
Massachusetts General Hospital
OTHER